Vector Science and Therapeutics (TSXV:PAIN) EPS (Basic): C$-0.31 (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:PAIN Vector Science and Therapeutics Corp TSXV:PAIN
14 GF Score
Price C$1.55
View Full Analysis

What is Vector Science and Therapeutics EPS (Basic)?

Vector Science and Therapeutics TSXV:PAIN -4.32% 14 EPS (Basic) is C$-0.31 as of Feb. 2026. GuruFocus rates TSXV:PAIN with a GF Score™ of 14/100.

Vector Science and Therapeutics's basic earnings per share (Basic EPS) for the three months ended in Feb. 2026 was C$-0.06. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Feb. 2026 was C$-0.31.

Vector Science and Therapeutics's EPS (Diluted) for the three months ended in Feb. 2026 was C$-0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was C$-0.31.

Vector Science and Therapeutics's EPS without NRI for the three months ended in Feb. 2026 was C$-0.08. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2026 was -0.29.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Vector Science and Therapeutics  (TSXV:PAIN) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Vector Science and Therapeutics EPS (Basic) Related Terms

Vector Science and Therapeutics EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Vector Science and Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vector Science and Therapeutics EPS (Basic) Chart

Vector Science and Therapeutics Annual Data
Trend Aug24 Aug25
EPS (Basic)
0.00 -0.23

Vector Science and Therapeutics Quarterly Data
Aug24 Nov24 Aug25 Nov25 Feb26
EPS (Basic) 0.00 0.00 0.00 -0.25 -0.06
TSXV:PAIN
14GF Score
Vector Science and Therapeutics Corp TSXV:PAIN
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vector Science and Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Vector Science and Therapeutics's Basic EPS for the fiscal year that ended in Aug. 2025 is calculated as

Basic EPS (A: Aug. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.239-0)/5.500
=-0.23

Vector Science and Therapeutics's Basic EPS for the quarter that ended in Feb. 2026 is calculated as

Basic EPS (Q: Feb. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.329-0)/5.500
=-0.06

EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of C$-0.31 mean?
Vector Science and Therapeutics (TSXV:PAIN) has a EPS (Basic) of C$-0.31 as of Feb. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Vector Science and Therapeutics and its competitors.
Is Vector Science and Therapeutics' EPS (Basic) too high?
Vector Science and Therapeutics' current EPS (Basic) is C$-0.31. Overall, Vector Science and Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vector Science and Therapeutics' EPS (Basic) compare to ABT and SYK?
Vector Science and Therapeutics' EPS (Basic) of C$-0.31 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Vector Science and Therapeutics and its competitors. Vector Science and Therapeutics's current EPS (Basic) is C$-0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vector Science and Therapeutics stock overvalued right now?
Vector Science and Therapeutics (TSXV:PAIN) has a current EPS (Basic) of C$-0.31. The current EPS (Basic) is C$-0.31. Vector Science and Therapeutics' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Vector Science and Therapeutics (TSXV:PAIN), the current EPS (Basic) is C$-0.31 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vector Science and Therapeutics Business Description

Vector Science and Therapeutics Corp develops novel biomechanical devices and active transdermal drug and peptide delivery platforms to equip clinicians with non-systemic, localized interventions targeting a broad cross-section of diseases and conditions where systemic delivery of interventions compromises the therapeutic effect or introduces unacceptable harm.
14GF Score

Get the complete analysis for TSXV:PAIN

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.55
Price